niacinamide has been researched along with Cancer of the Urinary Tract in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is an oral multikinase inhibitor that blocks cell proliferation via the ERK pathway and angiogenesis via the VEGF pathway." | 2.76 | A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium. ( Blattler, C; Eisen, A; Hotte, SJ; McWhirter, E; Moore, MJ; Mukherjee, SD; Sridhar, SS; Tannock, IF; Wang, L; Winquist, E; Wright, JJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krege, S | 1 |
| Rexer, H | 1 |
| vom Dorp, F | 1 |
| de Geeter, P | 1 |
| Klotz, T | 1 |
| Retz, M | 1 |
| Heidenreich, A | 1 |
| Kühn, M | 1 |
| Kamradt, J | 1 |
| Feyerabend, S | 1 |
| Wülfing, C | 1 |
| Zastrow, S | 1 |
| Albers, P | 1 |
| Hakenberg, O | 1 |
| Roigas, J | 1 |
| Fenner, M | 1 |
| Heinzer, H | 1 |
| Schrader, M | 1 |
| Sridhar, SS | 1 |
| Winquist, E | 1 |
| Eisen, A | 1 |
| Hotte, SJ | 1 |
| McWhirter, E | 1 |
| Tannock, IF | 1 |
| Mukherjee, SD | 1 |
| Wang, L | 1 |
| Blattler, C | 1 |
| Wright, JJ | 1 |
| Moore, MJ | 1 |
| Miyake, H | 1 |
| Fujisawa, M | 1 |
1 review available for niacinamide and Cancer of the Urinary Tract
| Article | Year |
|---|---|
[Molecular targeted therapy for renal cell carcinoma and other urological cancers].
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; | 2010 |
2 trials available for niacinamide and Cancer of the Urinary Tract
| Article | Year |
|---|---|
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Double-Blind Method; | 2014 |
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Female; Humans; Male; Midd | 2011 |